Cashman N, Martin C, Eizenbaum J F, Degos J D, Bach M A
J Clin Invest. 1982 Aug;70(2):387-92. doi: 10.1172/jci110628.
To determine if previously reported peripheral blood suppressor cell defects are also found in the central nervous system (CNS) of patients with multiple sclerosis (MS), we studied cerebrospinal fluid (CSF) and peripheral blood lymphocytes from 40 MS patients and 15 patients with other neurological diseases. With an indirect immunofluorescence technique using the OKT series of monoclonal antibodies (OKT4, marking helper/inducer cells, OKT5 and OKT8 marking suppressor/cytotoxic cells, and OKT3 marking all peripheral T cells) we found that MS patients tested in the first 2 wk of exacerbation had invariably diminished CSF suppressor/cytotoxic cells, which was followed by an elevation of these cells in the 3rd wk of exacerbation. Repeat studies of three patients showed that perturbations of CSF suppressor/cytotoxic cells were dependent on clinical status. These observations add to the accumulating data that suggest altered immunity in the pathogenesis of MS.
为了确定先前报道的外周血抑制细胞缺陷是否也存在于多发性硬化症(MS)患者的中枢神经系统(CNS)中,我们研究了40例MS患者和15例患有其他神经系统疾病患者的脑脊液(CSF)和外周血淋巴细胞。使用OKT系列单克隆抗体的间接免疫荧光技术(OKT4标记辅助/诱导细胞,OKT5和OKT8标记抑制/细胞毒性细胞,OKT3标记所有外周T细胞),我们发现,在病情加重的前2周进行检测的MS患者,其脑脊液抑制/细胞毒性细胞总是减少,而在病情加重的第3周这些细胞会升高。对三名患者的重复研究表明,脑脊液抑制/细胞毒性细胞的扰动取决于临床状态。这些观察结果进一步支持了越来越多的数据,这些数据表明在MS发病机制中免疫功能发生了改变。